MALIGNANT HYDATIDIFORM MOLE

MALIGNANT HYDATIDIFORM MOLE was reported 6 times

MALIGNANT HYDATIDIFORM MOLE is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Actinomycin [EPC] 1 0.0005
1 Photoenhancer [EPC] 1 0.0003
2 Non-Standardized Plant Allergenic Extract [EPC] 1 0.0001
3 Alkaloid [EPC] 1 0.0000
4 Aminosalicylate [EPC] 2 0.0000
5 Topoisomerase Inhibitor [EPC] 1 0.0000
6 Non-Standardized Food Allergenic Extract [EPC] 1 0.0000
7 Aromatase Inhibitor [EPC] 1 0.0000
8 Alkylating Drug [EPC] 1 0.0000
9 Platinum-based Drug [EPC] 1 0.0000
10 Vitamin D [EPC] 1 0.0000
11 Vitamin C [EPC] 1 0.0000
12 Folate Analog Metabolic Inhibitor [EPC] 1 0.0000
13 Proton Pump Inhibitor [EPC] 1 0.0000
14 Tumor Necrosis Factor Blocker [EPC] 1 0.0000